He Xuanhong, Lu Minxun, Zou Chang, Li Zhuangzhuang, Gong Taojun, Kenmegne Guy Romeo, Wang Yitian, Luo Yi, Zhou Yong, Min Li, Tu Chongqi
Department of Orthopedics, Orthopedic Research Institute, Trauma Center West China Hospital, Sichuan University, No. 37 Guo Xue Xiang, Chengdu, 610041, Sichuan, People's Republic of China.
Department of Model Worker and Innovative Craftsman, West China Hospital, Sichuan University, No. 37 Guoxuexiang, Chengdu, 610041, Sichuan, People's Republic of China.
J Orthop Surg Res. 2024 May 2;19(1):273. doi: 10.1186/s13018-024-04728-6.
Talar malignant tumor is extremely rare. Currently, there are several alternative management options for talus malignant tumor including below-knee amputation, tibio-calcaneal arthrodesis, and homogenous bone transplant while their shortcomings limited the clinical application. Three-dimensional (3D) printed total talus prosthesis in talus lesion was reported as a useful method to reconstruct talus, however, most researches are case reports and its clinical effect remains unclear. Therefore, the current study was to explore the application of 3D printed custom-made modular prosthesis in talus malignant tumor.
We retrospectively analyzed the patients who received the 3D printed custom-made modular prosthesis treatment due to talus malignant tumor in our hospital from February 2016 to December 2021. The patient's clinical data such as oncology outcome, operation time, and volume of blood loss were recorded. The limb function was evaluated with the Musculoskeletal Tumor Society 93 (MSTS-93) score, The American Orthopedic Foot and Ankle Society (AOFAS) score; the ankle joint ranges of motion as well as the leg length discrepancy were evaluated. Plain radiography and Tomosynthesis-Shimadzu Metal Artefact Reduction Technology (T-SMART) were used to evaluate the position of prosthesis and the osseointegration. Postoperative complications were recorded.
The average patients' age and the follow-up period were respectively 31.5 ± 13.1 years; and 54.8 months (range 26-72). The medium operation time was 2.4 ± 0.5 h; the intraoperative blood loss was 131.7 ± 121.4 ml. The mean MSTS-93 and AOFAS score was 26.8 and 88.5 respectively. The average plantar flexion, dorsiflexion, varus, and valgus were 32.5, 9.2, 10.8, and 5.8 degree respectively. One patient had delayed postoperative wound healing. There was no leg length discrepancy observed in any patient and good osseointegration was observed on the interface between the bone and talus prosthesis in all subjects.
The modular structure of the prosthesis developed in this study seems to be convenient for prosthesis implantation and screws distribution. And the combination of solid and porous structure improves the initial stability and promotes bone integration. Therefore, 3D printed custom-made modular talus prosthesis could be an alternative option for talus reconstruction in talus malignant tumor patients.
距骨恶性肿瘤极为罕见。目前,距骨恶性肿瘤有几种可供选择的治疗方案,包括膝下截肢、胫跟关节融合术和同种异体骨移植,但其缺点限制了临床应用。三维(3D)打印全距骨假体用于距骨病变的报道显示是一种重建距骨的有效方法,然而,大多数研究为病例报告,其临床效果仍不明确。因此,本研究旨在探讨3D打印定制模块化假体在距骨恶性肿瘤中的应用。
我们回顾性分析了2016年2月至2021年12月在我院因距骨恶性肿瘤接受3D打印定制模块化假体治疗的患者。记录患者的肿瘤学结局、手术时间和失血量等临床数据。采用肌肉骨骼肿瘤学会93(MSTS-93)评分、美国矫形足踝协会(AOFAS)评分评估肢体功能;评估踝关节活动范围以及下肢长度差异。采用X线平片和岛津金属伪影减少技术断层合成(T-SMART)评估假体位置和骨整合情况。记录术后并发症。
患者平均年龄和随访时间分别为31.5±13.1岁和54.8个月(范围26 - 72个月)。中位手术时间为2.4±0.5小时;术中失血量为131.7±121.4毫升。MSTS-93和AOFAS评分的平均值分别为26.8和88.5。跖屈、背屈、内翻和外翻的平均值分别为32.5度、9.2度、1\0.8度和5.8度。1例患者术后伤口愈合延迟。所有患者均未观察到下肢长度差异,所有受试者的骨与距骨假体界面均观察到良好的骨整合。
本研究开发的假体模块化结构似乎便于假体植入和螺钉分布。实心和多孔结构的结合提高了初始稳定性并促进了骨整合。因此,3D打印定制模块化距骨假体可能是距骨恶性肿瘤患者距骨重建的一种替代选择。